BFRI
Biofrontera Inc
NASDAQ · Pharmaceuticals
$0.82
-0.02 (-2.02%)
Open$0.87
Previous Close$0.84
Day High$0.88
Day Low$0.81
52W High$35.77
52W Low$17.17
Volume—
Avg Volume563.4K
Market Cap9.56M
P/E Ratio16.67
EPS$2.03
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+5,327.5% upside
Current
$0.82
$0.82
Target
$44.56
$44.56
$28.75
$44.56 avg
$50.07
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.84M | 1.67M | 1.59M |
| Net Income | 546.1K | 470.0K | 528.6K |
| Profit Margin | 29.7% | 28.1% | 33.2% |
| EBITDA | 946.1K | 856.8K | 789.7K |
| Free Cash Flow | 614.9K | 585.2K | 384.5K |
| Rev Growth | +2.3% | +24.3% | +24.6% |
| Debt/Equity | 0.14 | 0.16 | 0.18 |
Dividend
Dividend Yield3.23%
Annual Dividend$1.09
Payout Ratio53.8%
Frequencyquarterly
Ex-DividendMar 30, 2026
Pay DateApr 15, 2026
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |